SCHEMBL7707534

SCHEMBL7707534

O=C1CC(c2ccc(OC3CCCC3)c3oc4ccccc4c23)CN1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.48
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 2/20 0.48
PDE4A P27815 10/20 0.47
PDE4B Q07343 8/20 0.47
PDE4C Q08493 8/20 0.47
PDE4D Q08499 8/20 0.47
CYP3A4 P08684 2/20 0.47
LMNA P02545 2/20 0.47
KDM4E B2RXH2 2/20 0.47
VEGFA P15692 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
CREBBP Q92793 1/20 0.47
PDE5A O76074 1/20 0.47
TNF P01375 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705507 0.85 PDE10A (0.51) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL7711514 0.84 MTNR1A (0.45) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL7703632 0.74 PDE10A (0.59) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL8272339 0.73 MAOA (0.50) CYP19A1CYP11B1CYP11B2PDE4BLMNA
SCHEMBL8271346 0.73 PDE4B (0.41) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL8272330 0.73 PDE4B (0.41) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL5018006 0.73 CYP19A1 (0.49) CYP19A1CYP11B1CYP11B2PDE4APDE4B
SCHEMBL2559533 0.72 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL2556256 0.72 PDE4A (0.44) PDE4APDE4BPDE4CPDE4DCYP3A4
SCHEMBL7704619 0.72 PDE4A (0.48) CYP19A1CYP11B1CYP11B2PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011132051-A2 TRICYCLE COMPOUNDS AS PHOSPHODIESTERASE-10 INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-10-27 WO disclosed